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Abstract
Background: Physician–nurse task shifting in primary care appeals greatly to health policymakers. It promises to
address workforce shortages and demands of high-quality, affordable care in the healthcare systems of many countries.
This systematic review was conducted to assess the evidence about physician–nurse task shifting in primary care in
relation to the course of disease and nurses’ roles.
Methods: We searched MEDLINE, Embase, The Cochrane Library and CINAHL, up to August 2012, and the reference list
of included studies and relevant reviews. All searches were updated in February 2014. We selected and critically
appraised published randomized controlled trials (RCTs).
Results: Twelve RCTs comprising 22 617 randomized patients conducted mainly in Europe met the inclusion criteria.
Nurse-led care was delivered mainly by nurse practitioners following structured protocols and validated instruments in
most studies. Twenty-five unique disease-specific measures of the course of disease were reported in the 12 RCTs.
While most (84 %) study estimates showed no significant differences between nurse-led care and physician-led care,
nurses achieved better outcomes in the secondary prevention of heart disease and a greater positive effect in
managing dyspepsia and at lowering cardiovascular risk in diabetic patients. The studies were generally small, of
varying follow-up episodes and were at risk of biases. Descriptive details about roles, qualifications or interventions
were also incomplete or not reported.
Conclusion: Trained nurses may have the ability to achieve outcome results that are at least similar to physicians’ for
managing the course of disease, when following structured protocols and validated instruments. The evidence,
however, is limited by a small number of studies reporting a broad range of disease-specific outcomes; low reporting
standards of interventions, roles and clinicians’ characteristics, skills and qualifications; and the quality of studies. More
rigorous studies using validated tools could clarify these findings.
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Resumen
Antecedentes: La transferencia de tareas del médico a profesionales de enfermería en atención primaria atrae
enormemente a los legisladores de salud. Esta estrategia promete abordar la escasez de recursos humanos y
demandas de atención asequible y de alta calidad en los sistemas de salud de muchos países. Realizamos una
revisión sistemática para evaluar la evidencia sobre la transferencia de tareas médico-enfermería en atención
primaria con relación al curso de la enfermedad y a las funciones de enfermería.
Métodos: Realizamos búsquedas en los registros de Medline, Embase, Cochrane Library y CINAHL, hasta Agosto del
2012; y en las listas de referencia de los estudios incluidos y de revisiones sistemáticas relevantes. Actualizamos las
búsquedas en Febrero del 2014. Seleccionamos y realizamos una valoración crítica de los ensayos controlados
aleatorios (ECA) ya publicados.
Resultados: Doce ECA realizados principalmente en Europa con 22 617 participantes asignados al azar reunieron
los criterios de inclusión. Profesionales de enfermería, principalmente enfermeras médico, dieron el cuidado de
atención, mayormente mediante el uso de protocolos estructurados e instrumentos validados. Se reportaron
veinticinco medidas únicas del curso de la enfermedad. La mayoría (84 %) de éstas mostraron diferencias no
significativas entre grupos, pero el profesional de enfermería consiguió tasas de pacientes significativamente
mejores que el médico en la prevención secundaria de enfermedades cardiacas, un efecto positivo mayor en el
manejo de dispepsia, y en la reducción del riesgo cardiovascular en pacientes diabéticos. Los estudios fueron
generalmente pequeños, de seguimiento variado, y vulnerables a sesgos de selección, detección y deserción.
Descripciones de las funciones, calificaciones e intervenciones no se reportan o son incompletas.
Conclusión: Profesionales de enfermería capacitados podrían obtener resultados de similitud al médico en el
manejo del curso de la enfermedad, mediante el seguimiento de protocolos estructurados e instrumentos
validados. La evidencia, sin embargo, se limita a un pequeño número de estudios que reportan una amplia gama
de resultados de enfermedades específicas, y un bajo estándar en el reporte de intervenciones, características y
funciones del profesional clínico, habilidades y calificaciones; y por la calidad de los estudios. Estudios con mejor
calidad de métodos, que utilicen herramientas validadas podrían aclarar estos hallazgos.
Background
Chronic illness and disability are major contributing fac-
tors of morbidity and mortality worldwide. Long life
spans and ageing populations are already imposing a
major challenge for the infrastructures of healthcare sys-
tems [1]. These factors and patients’ expectations give
rise to professional care-giving demands, consequently
increasing the need for more activity in the community,
ambulatory and primary care. There is currently a global
shortage of 7.2 million physicians, nurses and midwives,
however, and this number is estimated to increase to
about 12.9 million by 2035 [2].
A popular approach to overcome this increasing short-
age of human resources is task shifting, a process of
delegation whereby tasks are moved to less specialized
healthcare workers [3]. The strategy aims to efficiently
and effectively reorganize the existing healthcare human
resources to improve the distribution of workload, in-
crease service capacity and reduce healthcare costs [4, 5].
Physician–nurse task shifting is carried out by transferring
specific functions or tasks traditionally from the domain
of physicians to nurses. Nurses are less costly to employ
and train than physicians and are one of the largest groups
of qualified healthcare providers [6]. In many countries,
nurses are being granted more responsibilities and a wider
range of clinical tasks [7]. This means that nurses might
have a key role in medical areas where workforce short-
ages are a major health issue. Chronic conditions, for ex-
ample, depend on resourceful caregiving, a long-term
plan, continuous monitoring and adherence to disease
management to achieve better health outcomes [8].
Two reviews suggested that nurses can provide same
quality care and achieve as-good health outcomes as pri-
mary care physicians, but the volume and methodological
quality of studies were insufficient [9, 10]. Measures of the
course of disease such as symptoms, severity and compli-
cations were rarely reported. These measures help in
monitoring the course of disease and treatment response
and can have a major impact on patient outcomes; some
may serve as surrogate measures of disease severity. We
systematically reviewed the evidence on the effectiveness
of physician–nurse task shifting in primary care in relation
to measures of the course of disease and nurses’ roles.
Methods
The protocol of our review followed a population, inter-
vention, comparison and outcome (PICO) approach [11]
and the recommended guidelines [12] for the reporting
of systematic reviews and meta-analyses (see Additional
file 1).
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Study identification
We searched MEDLINE (OVID), Embase (Elsevier),
CINAHL (EBSCOHost) and The Cochrane Library of
Systematic Reviews (Wiley) which includes the Cochrane
Effective Practice and Organization of Care Group. The
searches were not restricted by age, publication date or
country and included a study design filter for randomized
controlled trials (RCTs) and a combination of MeSH
terms, text words, free text terms and synonyms for “pri-
mary care”, “skill mix”, “doctors”-“nurse” “substitution”
(see Additional file 2). Additional publications were identi-
fied by manual searches of the reference lists of included
studies and relevant reviews. All searches were carried out
to cover publications from the inception of databases to
August 2012 and were updated in February 2014.
Study inclusion and exclusion criteria
We included peer-reviewed RCTs published in English
that examined task shifting from physicians to nurses in
primary care (general practices, community or ambula-
tory care settings). Studies were eligible if care from
family physicians, paediatricians and/or geriatricians was
compared to care delivered by nurses (nurse-led care) in
all roles under a task-shifting model of care and for pa-
tients of all ages and all conditions, and if studies re-
ported outcome measures related to the course of
disease including symptoms, severity and complications.
We excluded measures of quality of life, satisfaction,
mortality, hospital admissions, process of care or clinical
parameters that were not surrogates of the course of
disease.
We focused on a task-shifting approach by differentiat-
ing it from supplementation based on the framework
from a Cochrane review [10]. Under task shifting, clearly
delineated tasks or functions traditionally from the do-
main of physicians are transferred to nurses [3]. Nurses
may receive specific or competency-based training to
perform such tasks/functions and would deliver consul-
tations with autonomous or delegated responsibility.
Studies of task shifting thus compare the performance
between nurses (as main figure of care) and physicians
when both manage the same work or tasks in a similar
capacity. In a supplementation approach, nurses com-
plement the work of physicians or extend the range of
services to improve the quality of care. Studies of sup-
plementation compare nurses working alongside other
clinicians (multi-professional service) with physicians
working alone (uni-professional service). We excluded
studies of supplementation.
Study selection and quality assessment
Two authors independently screened titles and abstracts
and assessed the full text of eligible publications and the
methodological features of included studies, resolving
differences by consensus. Based on well-established guide-
lines [13], we assessed the methodological features of
studies including core items of quality criteria that could
influence the risk of bias (sequence and allocation con-
cealment, blinding of participants, personnel and outcome
assessors and intention to treat (ITT)). Following the de-
bate about the validity of scores for the assessment of risk
of bias [14, 15], we did not calculate a composite score.
We describe the studies’ adequacy in each item with an
overall judgement of the quality of evidence.
Data abstraction
Structured data collection forms were used independ-
ently by two authors to abstract the bibliographic details,
population demographics, interventions (training com-
petency, roles, type of care, clinical responsibility, use of
guidelines, follow-up length) and outcome data (in all
forms, for example, binary, continuous and/or semi-
quantitative) including the length of consultations in mi-
nutes. Differences were resolved through consensus.
Based on the studies’ description of interventions and
competencies, we categorized nurses into the following:
nurse practitioner (NP) or NP with additional degree/
courses (NP+), for example, NP with Master degree; reg-
istered nurse (RN); or licensed nurse (LN). Outcomes
were grouped according to disease area, for example,
heart disease for heart failure and coronary heart disease.
Data from a single study reported across various publi-
cations were extracted as one unit. Publications report-
ing more than one RCT were extracted as separate
studies.
Data synthesis
Data were analysed based on the individual trial estimates.
Using Review Manager (Version 5.1) [16], we calculated
the unadjusted relative risks (RRs) or the weighted mean
differences (WMDs) and 95 % confidence intervals (CI) of
the absolute end points. There was mostly one study per
outcome which precluded the ability to perform meta-
analyses. We tabulated the effect sizes, and the results
were synthesized narratively. We considered P < 0.05 to
imply statistical significance. Following established tech-
niques [17], standard deviations were estimated using the
information from the studies’ statistical analyses.
Results
Study identification
Figure 1 shows the flow of study selection. Our literature
searches identified 4 589 original records. Based on screen-
ing of titles and abstracts, 268 records were eligible for de-
tailed examination of full-text publications; 44 of these
were relevant for appraisal, but we excluded 27 for the rea-
sons provided in Additional file 3. Twelve RCTs reported
in 17 publications [18–34] met the inclusion criteria.
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Study and population characteristics
Table 1 provides the summary characteristics of studies
in review including the study design, setting, population
demographics and interventions (see Additional file 4
for a detailed description). The trials were conducted
in the UK (n = 6), the Netherlands (n = 3), South Africa
(n = 2) and Russia (n = 1). More than one follow-up epi-
sode was reported in a few cases; median of maximum
follow-up was 6 (range: 0.5–48) months. The 12 trials
comprised of 22 617 enrolled or randomized patients
(range: 100–9 252); 4 had less than 200 patients (range:
100–175). Mean age in 10 trials and ranged from 35 (SD
9.63) to 69.5 (SD 10.6) years; median age was 27.6 (IQR:
9.0–44.9) in another trial, and patients’ age ranged from 0
to >75 years in another one, and 34.7 % of the population
were male.
Task shifting was carried out in general practices,
nurse clinics and healthcare centres, for a wide range of
possible diagnoses (diverse, minor acute, common or spe-
cific, for example, hypertension) in patients requiring
single-contact care, single-contact and urgent care and/or
ongoing care. The tasks varied widely from assessment,
history taking, preparation, diagnostic, monitoring and
prescription to decisions on eligibility for and initiation of
treatment, referral, follow-up and secondary prevention.
Description of nurses’ competencies and training compo-
nents often lacked enough detail. The number of partici-
pating nurses and physicians was reported in 10 and 6
trials; the median number was 11 (range: 1–103) and 12
(range: 5–50), respectively. Nurses performed roles of NPs
in eight trials, LNs in three trials and LNs and NPs in one
trial. Nurses’ and physicians’ experience was reported in
four (range: 1–12 years) and one (16 years) trials, respect-
ively. Three trials stated the nurses’ educational degree: a
Masters in Advanced Nursing, a diploma in general prac-
tice and a special degree in patient education. Nurses de-
livered independent interventions in all trials but required
support from physicians in 11 trials and assumed full re-
sponsibility in 1 trial. All but two trials reported the use of
clinical guidelines or protocols.
Risk of bias in individual studies
The methodological assessment per quality item for each
trial is reported on Table 2. Ten trials individually assigned
Fig. 1 Illustration of the study selection process
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Table 1 Summary characteristics of studies included in review
Study Setting Population Nurse group Physician group Intervention
First author,
publication (y)
Location Design,
perioda
Facilities, n Diagnosis Nurses
(n)
Patients
(N)
Mean age
(SD), y
Male,
%
Phys.,
(n)
Patients
(N)
Mean age
(SD), y
Male,
%
By FCA GDL 1st C UV OC C, n FUP,
months
Fairall et al.,
2012 [25]
ZA 2 cRCT2,
2008–2010
Nurse ART
clinic, 31
HIV/AIDS 103 3029 38.0 (8.9) 30 nr 3202 38.0 (9.6) 27 LN n y n n y >1 12–18
Fairall et al.,
2012 [25]
ZA 1 cRCT1,
2008–2010
Nurse ART
clinic, 31
HIV/AIDS 103 5390 36.0 (9.6) 33 nr 3862 35.0 (9.6) 31 LN n y n n y >1 12–18
Houweling et al.,
2011 [27]
NL 3 RCT,
period nr
Practice, 1 DM2 2 116 67.1 (11.0) 53 5 114 69.5 (10.6) 42 NP y y n n y >1 14
Andryukhin et al.,
2011 [18]
RU 1 RCT,
2006–2009
Medical
centre
practice, 1
Heart failure
with preserved
ejection fraction
10 50 66.5 (3.2) 27 8 50 68.0 (4.3) 34 NP/LN n y n n y >1 6
Dierick-van Daele
et al., 2009 [24]
NL 2 RCT, 2006 Practice, 15,
Reference, 5
Common
complaints
12 817 42.8 (16.5) 38 50 684 46.1 (16.6) 40 NP+ n y y n n 1 0.5
Chan et al.,
2009 [22]
UK 6 RCT,
2002–2004
Nurse
clinic, 1
GORD, moderate
gastritis, dyspepsia
after direct access
gastroscopy
nr 89 50.2 (13.9) 49 nr 86 48.4 (12.8) 49 NP+ n y n n y >1 6
Hesselink et al.,
2004 [26]
NL 1 RCT,
1998–2002
Practice, 12 Asthma and
COPD
2 139 49.9 (14.2) 35 14 137 44.7 (13.6) 28 LN n y n n y >1 0.5, 12, 24
Denver et al.,
2003 [23]
UK 5 RCT,
2000–2001
Nurse
hospital-based
hypertension
clinic, n= nr
DM2,hypertension,
under blood
pressure lowering
treatment
nr 60 58.1 (13.8) 57 nr 60 62.4 (9.1) 70 NP+ n y n n y >1 6
Kernick et al.,
2000 [28]
UK 4 RCT,
period nr
Health
centre, 1
Psoriasis and
eczema
1 55 47.4 (18.4) 39 nr 54 51.7 (15.8) 48 NP+ n y n n y >1 4
Kinnersley et al.,
2000 [34]
UK 3 RCT,
period nr
Practice, 10 Diverse
conditions
12 1465b range:
0–>75
39 10 1465b range:
0–>75
42 NP n nr y y n 1 0.5
Shum et al.,
2000 [32]
UK 2 RCT,
1998–1999
Practice, 5 Acute minor
illnesses
5 900 IQR:26.0
(9.0–41.7)
40 19 915 IQR:29.1
(9.7–44.9)
40 NP n nr y y n ≥1 0.5
Campbell et al.,
1998 [19–21,
29–31, 33]
UK 1 RCT,
1995–1996
Practice, 19 CHD secondary
prevention
28 673 65.9 (7.9) 58 nr 670 66.3 (8.3) 58 NP n y n n y >1 12, 48
Studies are listed by year (y) of publication, in decreasing order
Phys. (n): number of physicians; Nurses (n): number of nurses; Patients (N): number of patients enrolled (Fairall et al. 2012 [25]) or randomized; SD: standard deviation; UK: United Kingdom; NL: The Netherlands; ZA:
South Africa; RU: Russia; RCT: randomized controlled trial; cRCT: cluster randomized controlled trial; Facilities n: number of facilities; DM (2): diabetes mellitus (type 2); GORD: gastro-esophageal reflux disease; COPD:
chronic obstructive pulmonary disease; CHD: coronary heart disease; IQR: interquartile ranges; NP: nurse practitioner; NP+: nurse practitioner with additional degrees/courses; LN: licensed nurse; FCA: full clinical autonomy;
GDL: guideline/(semi-structured)protocol-based interventions; 1stC.: 1st contact; UV: urgent visits; OC: ongoing care; C (n): number of consultations; FUP: length of follow-up; y: yes; n: no; nr: not reported
aStart and end year when studies were conducted
bNumber of randomized patients per group not reported
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patients to intervention groups and two randomized 31
clinics with 103 nurses. No trial fulfilled all the quality cri-
teria assessed. Ten trials reported patient inclusion and
exclusion criteria and seven measured the intervention by
definition of a primary outcome. The trials were at risk of
selection bias since only six had adequate random se-
quence generation and allocation concealment. No trial
reported blinding of patients and providers, and three per-
formed blinded assessment of outcomes, making trials
vulnerable to performance and detection biases. Eleven
trials reported to have calculated sample sizes, eight had
at least 20 % attrition (overall range: %: 24–59) and seven
reported the use of intention-to-treat techniques to deal
with missing data. Nine trials reported the funding sources;
one was industry funded.
Outcomes
Twenty-five different measures of the course of disease
were reported for a wide range of conditions (Table 3).
All but three [24, 26] of the measures were taken using
validated methods, and the follow-up time span varied
widely.
Heart disease
In one trial, NPs delivered care techniques to facilitate
behavioural change following clinical guidelines to per-
form secondary prevention of coronary heart disease
(CHD) [20]. In a time span of 12 or 48 months, nurse-
led care showed no significant differences to physician-
led care in the number of patients with chest pain,
reflected on the Angina TyPe specification scale and the
SF-36 questionnaire. In a time span of 12 months, how-
ever, nurse-led care showed significantly fewer patients
(7.1 %), compared to physician-led care (10.8 %), who re-
ported worsening (little or much worse) chest pain (RR
0.66, 95 % CI 0.44 to 0.98). This difference levelled off at
48 months.
In another trial, LNs and/or NPs delivered patient
education, treatment, exercise and training information
and counselling following clinical guidelines to manage
heart failure with preserved ejection fraction [18]. In a
time span of 6 months, nurse-led care showed no signifi-
cant differences to physician-led care in the number of
patients with positive changes in heart failure class,
reflected on the New York Heart Association Functional
Classification tool: positive changes meant regression of
class or stay within class I.
Lung disease
In one trial, LNs delivered patient education and followed
structured protocols to manage asthma and chronic ob-
structive pulmonary disease [26]. In a time span of 12 and
24 months, both nurse-led care and physician-led care
showed a small (mean change) improvement in dyspnea
scores, but the differences were not significant, reflected
on the Medical Research Council Questionnaire. The trial
also showed no significant differences between groups in
the number of patients in whom chronic cough, phlegm
Table 2 Methodological features of included studies
Study Inclusion and
exclusion
criteria
Outcome Sequence
generation
Allocation
concealment
Blinding Sample Attrition,
%
Funding
First author Location 1ry 2ry calc. size
Fairall et al., 2012 [25] ZA 2 ✓ ✓ ✓ A A d ✓e ≥200 <20 G
Fairall et al., 2012 [25] ZA 1 ✓ ✓ ✓ A A d ✓e ≥200 ≥20 G
Houweling et al., 2011 [27] NL 3 ✓ ✓ ✓ I A NP ✓ ≥200 <20 G
Andryukhin et al., 2011 [18] RU 1 ✓ U I c ✓e <200 ≥20 None
Dierick-van Daele et al., 2009 [24] NL 2 ✓ A A NP ≥200 ≥20 G
Chan et al., 2009 [22] UK 6 ✓ A A b ✓ <200 <20 nr
Hesselink et al., 2004 [26] NL 1 a ✓ ✓ U U b ✓ ≥200 ≥20 nr
Denver et al., 2003 [23] UK 5 a ✓ ✓ I I NP ✓e <200 <20 nr
Kernick et al., 2000 [28] UK 4 ✓ ✓ A U U ✓e <200 ≥20 Ind.
Kinnersley et al., 2000 [34] UK 3 ✓ ✓ ✓ A A NP ✓e ≥200 ≥20 G
Shum et al., 2000 [32] UK 2 ✓ A A NP ✓e ≥200 ≥20 G
Campbell et al., 1998 [19–21, 29–31, 33] UK 1 ✓ A I b ✓ ≥200 ≥20 G
Studies are listed by year (y) of publication, in decreasing order. A tick indicates the specific criteria fulfilled
Blinding: whether patients, care providers and/or outcome assessors were blinded; UK: United Kingdom; NL: the Netherlands; ZA: South Africa; RU: Russia. I:
inadequate; A: adequate; U: unclear; NP: not performed; G: government; Ind.: industry; P: private; nr: not reported
aInclusion criteria only
bBlinding of outcome assessors
cSingle blinding
dData analysts partly blinded
eIntention to treat strategies to deal with missing data
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Table 3 Effect estimates of studies in review
Study Nurses’
role
Population
diagnosis
Outcome Measurement
method/scale
FUP,
months
Nurse group Physician group Effect estimate
First author, y Location
Binary data n N n N RR (95 % CI)
Heart disease
Andryukhin et al., 2011 [18] RU 1 NP/LN Heart failure PEF Positiveb changes in
class HF
NYHA 6 18 40 8 35 1.97 (0.98 to 3.96)
Campbell et al., 1998
[19–21, 29–31, 33]
UK 1 NP CHD secondary
prevention
Chest pain ATyPeS/SF36a 12 232 508 250 498 0.91 (0.80 to 1.04)
Campbell et al., 1998
[19–21, 29–31, 33]
UK 1 NP CHD secondary
prevention
Chest pain ATyPeS/SF36 48 147 430 129 385 1.02 (0.84 to 1.24)
Campbell et al., 1998
[19–21, 29–31, 33]
UK 1 NP CHD secondary
prevention
Worsening chest pain ATyPeS/SF36 12 37 519 54 500 0.66 (0.44 to 0.98)
Campbell et al., 1998
[19–21, 29–31, 33]
UK 1 NP CHD secondary
prevention
Worsening chest pain ATyPeS/SF36 48 44 439 35 395 1.13 (0.74 to 1.73)
Lung disease
Hesselink et al., 2004 [26] NL 1 LN Asthma/COPD No chronic cough and
phlegm production or
an improvement
Present/absent 12 43 108 39 85 0.87 (0.63 to 1.20)
Hesselink et al., 2004 [26] NL 1 LN Asthma/COPD No chronic cough and
phlegm production or
an improvement
Present/absent 24 41 93 33 79 1.06 (0.75 to 1.49)
Hesselink et al., 2004 [26] NL 1 LN Asthma/COPD No wheezing or an
improvement in frequency
Never, ever, most
days and night
12 68 106 51 85 1.07 (0.85 to 1.34)
Hesselink et al., 2004 [26] NL 1 LN Asthma/COPD No wheezing or an
improvement in frequency
Never, ever, most
days and night
24 53 93 37 79 1.22 (0.91 to 1.63)
Infectious disease
Fairall et al., 2012 [25] ZA 2 LN HIV/AIDS Suppressed viral load in
patients receiving ARTd
Viral load 12–18 2156 3029 2230 3202 1.02 (0.99 to 1.06)
Fairall et al., 2012 [25] ZA 1 LN HIV/AIDS Suppressed viral load in
patients starting ARTd
Viral load 12–18 1706 2375 1062 1449 0.98 (0.94 to 1.02)
Diverse, acute and minor
conditions
Shum et al., 2000 [32] UK 2 NP Acute and minor Same, improved or cured
self-reported health status
Murphy 0.5 650 672 646 661 0.99 (0.97 to 1.01)
Kinnersley et al., 2000 [34] UK 3 NP Diverse conditions Same or improved
symptoms (much better,
better or unchanged)
Likert-type and
single reminders
0.5 472 484 515 529 1.00 (0.98 to 1.02)
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Table 3 Effect estimates of studies in review (Continued)
Continuous data Mean (SD) N Mean (SD) N WMD (95 % CI)
Lung disease
Hesselink et al., 2004 [26] NL 1 LN Asthma/COPD Mean change score
in dyspnea
MRCQTc 12 0.00 (1.3) 115 0.10 (1.3) 94 −0.10 (−0.45 to 0.25)
Hesselink et al., 2004 [26] NL 1 LN Asthma/COPD Mean change score
in dyspnea
MRCQTc 24 0.20 (1.4) 96 0.30 (1.3) 80 −0.10 (−0.50 to 0.30)
Metabolic disease
Denver et al., 2003 [23] UK 5 NP+ DM2 with
hypertension,
under BPLT
Mean fall in 10-year
CHD risk
Framingham
CHD risk score
6 −2.33 (3.87) 59 −0.33 (2.16) 56 −2.00 (−3.14 to −0.86)
Denver et al., 2003 [23] UK 5 NP+ DM2 with
hypertension,
under BPLT
Mean fall in 10-year
stroke risk
Framingham
stroke risk score
6 −4.33 (6.0) 59 −1.80 (3.53) 56 −2.53 (−4.32 to −0.74)
Digestive disease
Chan et al., 2009 [22] UK 6 NP+ GORD, moderate
gastritis
Mean score, dyspepsia
severity
GDSS (Gladys)
scoreg
6 4.90 (2.9) 89 7.20 (3.1) 86 −2.30 (−3.19 to −1.41)
Skin disease
Kernick et al., 2000 [28] UK 4 NP+ Psoriasis/eczema Mean score for
symptoms and severity
of skin condition
Self-evaluation
clinical scoree
4 7.60 (3.3) 35 8.1 (3.3) 46 −0.50 (−1.95 to 0.95)
Common complaints
Dierick-van Daele et al.,
2009 [24]
NL 2 NP+ Common
complaints
Mean difference in the
degree of burden of illness
LikertQTf 0.5 −1.77 (3.18) 473 −1.50 (2.63) 451 −0.27 (−0.65 to 0.11)
Dierick-van Daele et al.,
2009 [24]
NL 2 NP+ Common
complaints
Mean difference in the
concerns about illness
LikertQTf 0.5 −1.51 (3.20) 476 −1.40 (2.97) 450 −0.11 (−0.51 to 0.29)
Qualitative data
Metabolic disease
Houweling et al., 2011 [27] NL 3 NP DM2 Perceived burden of DM
symptoms and rating of
symptom troublesomeness
Type 2 Diabetes
Symptom Checklisth
14 “significant differences at follow-up for some of the Diabetes
Symptom Score dimensions (data not shown). After 14 months,
the mean sub-dimension scores for DM symptoms ‘fatigue’ and
‘cognitive distress’ and the total scores were lower in each
group, although no difference was observed between the
groups.”
Lung disease
Hesselink et al., 2004 [26] NL 1 LN Asthma/COPD Respiratory complaints
within two weeks after
intervention
Disturbance
(present/absent)
for >1 day or night
0.5 “no significant group differences in the number of days or
nights disturbed, OR 0.96 (95 % CI 0.56 to 1.61)”
M
artínez-G
onzález
et
al.H
um
an
Resources
for
H
ealth
 (2015) 13:55 
Page
8
of
14
Table 3 Effect estimates of studies in review (Continued)
Common complaints
Dierick-van Daele et al.,
2009 [24]
NL 2 NP+ Common
complaints
Complications due
to illness
Mean number of
days of work absence
0.5 “1.11 days (nurse, SD 0.32; physician, SD 0.31) of work absence
in average”
Dierick-van Daele et al.,
2009 [24]
NL 2 NP+ Common
complaints
Complications
due illness
Mean number of
days of inability
for daily activities
0.5 “no statistically significant differences between groups; mean
days unable for daily activities: nurse-led care 2.53 (SD 2.89),
physician-led care 2.69 (SD 2.90)”
Studies are listed in order of increasing length of follow-up, within each category of outcomes
UK: United Kingdom; NL: the Netherlands; ZA: South Africa; RU: Russia; n: number of patients or number of events; N: total number of patients per group; SD: standard deviation; RR: relative risk; WMD: weighted mean
difference; CI: confidence intervals; DM(2): diabetes mellitus (type 2); GORD: gastro-esophageal reflux disease; COPD: chronic obstructive pulmonary disease; CHD: coronary heart disease; BPLT: blood pressure lowering
treatment; PEF: preserved ejection fraction; MRCQT: Medical Research Council Questionnaire; LikertQT: Likert-type questionnaire; GDSS: Glasgow Dyspepsia Severity Score (Gladys); NYHA: New York Heart Association
Functional Classification; ATyPeS: Angina TyPe specification scale
aATyPeS is designed to use with the SF36 questionnaire to assess the presence, frequency and course of chest pain
bPositive changes mean regression of class or stay within class I of NYHA
cMRCQT ranking from 0 (no dyspnea) to 4 (very serious); positive mean values in each group indicate improvement; mean differences with negative values mean a reduction or improvement
dZA1 trial: patients starting ART whose results were available for at least 6 months. ZA2 trial: 76 % and 78 % of the patients in the intervention and control group, respectively, had been receiving ART for at least
2 years at the time of viral load measurements
eThree out of eight possible symptoms, each ranked from 1 (mild) to 5 (very severe). The sum score gave a clinical score from 3 (best state) to 15 (worst)
fLikert-type questionnaire ranking from 0 (excellent) to 10 (poor/worse); mean differences with negative values mean a reduction or improvement
gGDSS (Gladys) ranking from 0 (no symptoms) to 20 (symptoms)
h34-item scale based on yes/no questionnaires for perceived burden of symptoms including hyperglycemic, hypoglycemic, cardiac, neuropathic, psychological and vision-related. Summary responses ranked from 1
(symptom not occurred or not perceived as troublesome) to 5 (symptom extremely troublesome) on Likert-type scale
M
artínez-G
onzález
et
al.H
um
an
Resources
for
H
ealth
 (2015) 13:55 
Page
9
of
14
production and wheezing were absent or improved and in
the number of days or nights disturbed.
Metabolic disease
In one trial, NPs+ followed clinical guidelines to manage
hypertension in patients with type 2 diabetes mellitus
(DM2); no other details about the interventions deliv-
ered were reported [23]. In a time span of 6 months,
nurse-led care compared to physician-led care showed
that the differences in mean fall from baseline were sig-
nificantly lower for stroke risk (WMD −2.53, 95 % CI
−4.32 to −0.74) and CHD risk (WMD −2.00, 95 % CI
−3.14 to −0.86), reflected on the Framingham 10-year
stroke risk and the 10-year CHD risk scores.
In another trial, NPs followed clinical guidelines to
manage patients with DM2; no other details about the
interventions delivered were reported [27]. The trial
stated that in a time span of 14 months significant differ-
ences with nurse-led care were observed for some of the
DM2-related symptom score dimensions, reflected on
the revised version of DM2 Symptom Checklist. The
mean sub-dimension scores for fatigue, cognitive distress
and the total scores were stated to be lower in each
group.
Digestive disease
In one trial, NPs+ ran a follow-up clinic and managed
gastroscopy and dyspepsia according to guidelines; no
other details about the interventions delivered were re-
ported [22]. In a time span of 6 months, nurse-led care
significantly improved (maintained or reduced) dyspepsia,
compared to physician-led care, reflected in the Glasgow
Dyspepsia Severity Score (Gladys) (WMD −2.30, 95 % CI
−3.19 to −1.41).
Skin disease
In one trial, NPs+ managed and prescribed medications
for the management of psoriasis and eczema following a
dermatology manual; no other details about the inter-
ventions delivered were reported [28]. In a time span of
4 months, nurse-led care showed no significant differences
to physician-led care in the severity of skin condition and
symptoms for psoriasis and eczema, reflected in a sum-
mary clinical score for self-evaluation of symptoms.
Infectious disease
In one trial, LN assessed eligibility and prepared patients
for antiretroviral therapy (ART); monitored, prescribed
and initiated ART therapy; and referred patients to physi-
cians for ART initiation and re-prescriptions and followed
clinical guidelines for the management of HIV [25]. In a
time span of 12–18 months, nurse-led care compared to
physician-led care showed no significant differences in the
number of patients for whom suppressed viral load was
maintained while they were under ART; 77 % of the pa-
tients had ART for at least 2 years. In another trial, nurses
delivered the same interventions for HIV patients whose
viral load results were available for at least 6 months [25].
In a time span of 12–18 months, there were no signifi-
cant differences between groups in the number of pa-
tients for whom suppressed viral load was maintained
after starting ART.
Diverse, acute, minor or common complaints
In one trial, NPs performed history taking and physical
examinations, gave advice and prescribed treatment and
referrals, for the management of acute and minor illness
[32]. In another trial, NPs performed same-day consulta-
tions for diverse conditions; no other details about the
interventions delivered were reported [34]. Both trials
included children (Table 1). None of the trials reported
whether nurses followed clinical guidelines to deliver in-
terventions. In a time span of half a month, the two tri-
als showed no significant differences between groups in
the number of patients who reported their health status
as same, improved or cured, reflected on the Murphy
scale [32] and a Likert-type scale [34].
In another trial, NPs+ assessed symptoms, performed
clinical examinations and diagnosis, planned further
treatment, prescribed and performed referrals to primary
or secondary care, ordered clinical tests and examina-
tions and followed clinical guidelines for the manage-
ment of common complaints [24]. In a time span of half
a month, nurse-led care compared to physician-led care
showed no significant (mean) differences (before and
2 weeks after consultation) in the degree of burden of
illness and in the concerns about illness, reflected on a
Likert-type questionnaire. The trial also stated no signifi-
cant differences between groups in the mean number of
days for which patients reported being unable to per-
form daily activities due to illness. The stated average
number of days that patients missed their job due to ill-
ness was 1.11 days.
Length of consultations
Four trials [24, 27, 32, 34] reported the length of consul-
tations; all showed longer consultations by nurses than
by physicians (WMD range: 1.90–3.80 min; 95 % CI:
1.32 to 4.26).
The quality of studies was mixed, and sample sizes were
generally small. The three trials [20, 22, 23] in which the
intervention effects favoured nurse-led care were of lower
methodological quality (small study (N < 200), lack/un-
clear random generation and allocation concealment and/
or blinding and/or ≥20 % attrition). Among these, only one
[22] was superior in quality but used a small patient popu-
lation. A trial [25] of somehow higher quality (N > 3000,
better random generation and allocation concealment,
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<20 % attrition, some blinding) also showed no significant
differences between groups. Of the remaining trials, four
[24, 25, 32, 34] had larger patient populations and better
random generation and allocation concealment, but did
not fulfil blinding and/or attrition criteria.
Discussion
In this systematic review, we identified 12 trials aiming
to compare physician-led care with nurse-led care under
a task-shifting model in primary care. Nurse-led care
was provided mainly by nurse practitioners whose scope
expanded to a wide range of clinical domains and patient
populations. Nurses performed various tasks with differ-
ent degrees of clinical responsibility. They used clinical
guidelines and validated tools in most studies to deliver
care and monitor and identify disease-specific changes
of the course of disease. The volume of literature continues
to be low, however, and belongs mostly to European high-
income countries, mainly the UK and the Netherlands.
The evidence represents a wide range of disease-
specific measurements of disease progression, is at risk
of biases and consists of variable follow-up episodes.
Nevertheless, we found that nurse-led care was statisti-
cally not significantly different to physician-led care in
84 % of the patient outcomes reported. The remaining
16 % significantly favoured nurse-led care compared to
physician-led care. Nurses may thus have the ability to
meet the needs of healthcare systems with an increas-
ing shortage of physicians, in keeping with reports call-
ing for nurses to be used more and to perform greater
roles [7, 9, 10, 35].
The use of structured protocols that combine non-
pharmacological interventions with pharmacological
therapy and the use of validated tools in 75–84 % of the
studies might have resulted in better or similar care by
nurses than by physicians. It has been shown [36, 37]
that through delivering interventions that include educa-
tion, counselling and advice, nurses may encourage more
life changes and retain more patients in treatment
resulting in greater medication compliance, improve pre-
vention and better symptom control. Interventions that
include the provision of information about causes of ill-
ness and patients’ disease, for example, in the trial of pa-
tients with dyspepsia, may have also added benefits to
nurse-led care resulting in more motivated patients and
more effective (self-care) interventions in general. Re-
search has shown that patients generally want more in-
formation than they routinely receive from healthcare
professionals and that they like greater involvement in
the process of making decisions about their treatment
[38]. Good communication skills can also increase ad-
herence to treatment and outcome effectiveness [39, 40]
and may have led to more patients being involved in
their own care and treatment decisions.
The use of disease-specific protocols may have also
guided nurse-led care interventions to at least similar ef-
fectiveness as physicians-led care in the management of
stroke and CHD risk in diabetic patients. Disease-specific
protocols that include intensified non-pharmacological
programmes have indeed been associated with improved
cardiovascular risk factors but also with patient self-
efficacy and patient safety [41–43]. Using these protocols
may have also led nurses to successfully perform therapy
techniques that require safe (for example, inhalation) and
continuous management for conditions such as COPD
and asthma control. In addition, appropriate identification
and monitoring of disease changes have been recom-
mended to successfully engage and retain patients in care
[44, 45]. Following like-guidelines, nurses might have ap-
propriately quantified and monitored viral load, for ex-
ample, resulting in similar effectiveness to physician-led
care at maintaining suppressed viral load. In all, nurses
might have followed protocols more strictly resulting in
outcome improvements [46].
The long-term nature of chronic disease necessitates a
programme with an appropriate time span. It is unclear,
however, if the length of follow-up was adequate to iden-
tify a true effect; the studies do not report details about
the monitoring length needed to reflect a change. For
most of the studies, the time span was short, 6 months
or less. Disease complexity may have also resulted in
longer consultations by nurses than by physicians. In all
studies, nurses were trained and/or took courses for de-
livering the studies’ interventions. Further, nurses were
supported by physicians in most of the studies, suggest-
ing of the potential benefits of collaborative teams in the
improvement of patient outcomes, for example, reducing
modifiable risk factors [47, 48]. In a broader context, by
participating in these studies, nurse-led care patients
may have become more aware of their condition and
were thus more receptive to care resulting in better
outcomes.
It is uncertain to what extent nurses’ educational prep-
aration and type of nurses’ roles influenced the outcome
effects. The three trials that reported the nurses’ educa-
tional degree showed no significant differences. Al-
though nurses were in NP roles in 16 % (4/25) of the
outcomes that favoured nurse-led care, the studies were
of lower methodological quality somehow (lack/unclear
random generation and/or allocation concealment and/
or ≥20 % attrition and/or small study). Furthermore,
nurses were NPs and/or LNs in 84 % (21/25) of the out-
comes which showed no significant differences. Although
these studies were of variable quality, one trial of some-
how higher quality also had a bigger sample (N > 3000).
Future research could benefit from a more rigorous
methodology and better study reporting. Change in
health status over a time interval can occur due to the
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natural course of disease and/or as a result of the care
provided. Future studies should therefore report about
the regularity of disease monitoring needed to obtain an
improved outcome, consist of longer follow-up episodes
and continue using validated instruments. This could
lead to increased safety, effectiveness and improved
compliance to medication [36, 37]. Self-report scales
should be considered more carefully since these may not
be able to accurately detect the causes for the changes in
the course of disease. In order to understand how
nurses’ competencies and qualifications influence patient
outcomes and quality of care, future studies should map
all available nurses’ roles and consistently report the
educational qualifications and clinical responsibilities,
training and clinicians’ characteristics (for example,
nurse–physician–patient ratios and years of experience).
Reporting of intervention components as recently recom-
mended [49] could help to identify the benefits of this
strategy. The implementation of non-pharmacological
strategies should be further considered to improve disease
management and quality outcomes [50, 51].
Strengths and limitations of this systematic review
This is, to our knowledge, the first task-shifting system-
atic review with a focus on the study of measurements
of the course of disease. Although many measures were
reported, most were unique to each study precluding the
incorporation of meta-analyses. Where data were avail-
able, however, we report the trial estimates. Although
observational studies if well implemented could provide
important information, we only included RCTs because
these are at a lower risk of bias and allow the estimation
of causal effects. A small number of studies met the in-
clusion criteria, possibly because the number of studies
in this area is increasing slowly. We did not search for
grey literature, and we excluded publications reported in
languages other than English. We used thorough elec-
tronic and manual searches, however, and screened rele-
vant reviews (some in foreign languages) to identify all
relevant publications. It was difficult to understand the
level of nurses’ autonomy since nurses were supported
by physicians in most studies. In most cases, the inter-
ventions are not described in detail, and we could not
make clear judgments about nurses’ educational degree.
Conclusion
Trained nurses, mostly NPs, appeared to achieve out-
comes of at least similar effects as physicians for the man-
agement of disease progression in a wide range of patient
populations. Structured protocols and validated tools
might be some of the main boosters of outcome improve-
ment. The implementation of non-pharmacological and
patient-centred care approaches may also lead to success-
ful nurse-led care interventions. A clear definition of roles,
qualifications, skills and experience, essential for an ef-
fective and safe transfer of tasks and functions, is only
reported in low standards. It is therefore unclear to what
extent nurses should be involved in task shifting from
physicians. The evidence is also limited by the mixed
methodological quality of the trials, although a few of
the trials have larger patient populations. More good
quality studies using validated tools and larger samples
from many countries should improve the reporting stan-
dards and consistency of nurses’ roles, qualifications and
interventions.
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